Compare · CRON vs RGC
CRON vs RGC
Side-by-side comparison of Cronos Group Inc. (CRON) and Regencell Bioscience Holdings Limited (RGC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CRON and RGC operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- RGC is the larger of the two at $11.74B, about 11.5x CRON ($1.02B).
- Over the past year, CRON is up 40.4% and RGC is up 48.6% - RGC leads by 8.2 points.
- CRON has been more active in the news (9 items in the past 4 weeks vs 6 for RGC).
- CRON has more recent analyst coverage (11 ratings vs 0 for RGC).
- Company
- Cronos Group Inc.
- Regencell Bioscience Holdings Limited
- Price
- $2.71-0.91%
- $23.86+2.56%
- Market cap
- $1.02B
- $11.74B
- 1M return
- +2.26%
- -18.06%
- 1Y return
- +40.41%
- +48.60%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 9
- 6
- Recent ratings
- 11
- 0
Cronos Group Inc.
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under two adult-use brands, COVE and Spinach. The company also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Latest CRON
- Officer Doucet Terrence Gregory Joseph converted options into 10,597 shares and covered exercise/tax liability with 5,199 shares, increasing direct ownership by 5% to 110,588 units (SEC Form 4)
- Officer Wagner Adam converted options into 10,367 shares, increasing direct ownership by 11% to 103,987 units (SEC Form 4)
- Officer Buggy Shannon converted options into 20,622 shares and covered exercise/tax liability with 9,179 shares, increasing direct ownership by 7% to 178,322 units (SEC Form 4)
- Officer Kenost Jared Matthew converted options into 9,412 shares and covered exercise/tax liability with 3,701 shares, increasing direct ownership by 15% to 42,974 units (SEC Form 4)
- Officer Weigensberg Arye converted options into 3,118 shares, increasing direct ownership by 1% to 211,555 units (SEC Form 4)
- Officer Wagner Adam converted options into 20,470 shares, increasing direct ownership by 28% to 93,620 units (SEC Form 4)
- Officer Kenost Jared Matthew covered exercise/tax liability with 4,774 shares and converted options into 12,649 shares, increasing direct ownership by 27% to 37,263 units (SEC Form 4)
- SEC Form 10-Q filed by Cronos Group Inc.
- Cronos Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
- Cronos Expands Pre-Roll Portfolio with Spinach STIX®
Latest RGC
- SEC Form 4 filed by Director Lo William Wing Yan Dr
- SEC Form 4 filed by Director Hui Evana Yee Wah
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 424B5 filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited